Total Funding
86
65
Total FundingVenture - Series Unknown raised
Growth Score 86 in past quarter
-2 pts
Heat Score 65 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
118074
Bakhu Holdings produces, manufactures, and sells cannabis-related byproducts — sometimes referred to in the industry as cannabinoids.
- Maksim Selivanov: Chief Executive Officer & Chief Financial Officer, Finance
- Thomas Emmitt: CEO & Director
About the Company
Bakhu Holdings, Corp. holds a license to cell replication technology and related proprietary equipment, processes, and formulations to produce, manufacture, and sell cannabis-related byproducts—sometimes referred to in the industry as cannabinoids—exclusively in North and Central America and the Caribbean. Upon successful completion of an efficacy
demonstration of the commercial viability of the technology, we intend to exploit this intellectual property through sublicenses with third parties that will incorporate the cell replication technology into production plants they fund and build to produce medical, food additive, and recreational cannabis-related products.